Amarin (NASDAQ:AMRN) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Amarin (NASDAQ:AMRN – Get Free Report) posted its earnings results on Wednesday. The biopharmaceutical company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.02), Zacks reports. Amarin had a negative return on equity of 7.15% and a negative net margin of 16.33%. The business had revenue of $42.30 […]

Leave a Reply

Your email address will not be published.

Previous post Jerónimo Martins, SGPS (OTCMKTS:JRONY) Issues Earnings Results
Next post First Interstate Bank Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN)